cp wire

CP Wire Articles

Rocket Pharmaceuticals Releases Preclinical Data for First Investigational Gene Therapy Program for Rare Heart Disorder
  • Danon disease has an estimated prevalence of about 15,000-30,000 patients in the U.S. and E.U.
  • ... read more
Mon, 11/26/18 - 09:46 am
Cyclica Partners with Bayer to Advance its AI-Augmented Network of Cloud-Based Technologies

Cyclica announced on 11/26/18 a collaboration with Bayer to advance drug discovery programs by gaining insights into the polypharmacological profiles of small... read more

Mon, 11/26/18 - 09:34 am
Infant Bacterial Therapeutics Delays Ph III Start Date After Meeting with FDA
  • Trial expected to start in 1H2019
  • Improved protocol may allow for additional claims

Following its meeting with the US Food and Drug Administration (FDA) in Washington DC... read more

Sat, 11/24/18 - 11:06 am
Heat Biologics, Inc. Prices $12,000,000 Public Offering

Heat Biologics, Inc. ("Heat") (NASDAQ: HTBX), a biopharmaceutical company developing immunotherapies with the goal of activating a patient's immune system against cancer through T-cell activation... read more

Wed, 11/21/18 - 10:24 am
Cellanyx Publishes Clinical Proof-of-Concept Study of First-in-Class Biomarker Test to Determine Prostate Cancer Risk


Cellanyx and clinical collaborators today reported results of a prostate cancer clinical study demonstrating the ability of the company’s live tumor cell phenotypic biomarker test to identify... read more

Wed, 11/21/18 - 10:06 am

Pages